SEC Company Response from Electromed, Inc. (ELMD) (CIK 0001488917) (ELMD) — Aug 5, 2010
Electromed, Inc. (ELMD) (CIK 0001488917)
Date: Aug. 5, 2010 · CIK: 0001488917 · Accession: 0000897101-10-001568
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-166470
Letter
electromed103760_corresp.htm - Generated by SEC Publisher for SEC Filing
2100 LaSalle Plaza
800 LaSalle Avenue
Minneapolis, Minnesota 55402
August 5, 2010
612.492.8800 fax: 612.492.8899
wats: 866.655.3431
www.feltl.com
VIA EDGAR AND EMAIL
Securities and Exchange Commission
Attn: Ruairi Regan
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE:
Electromed, Inc.
Registration Statement on Form S-1 (File No. 333-166470)
Ladies and Gentlemen:
As underwriter of the offering by Electromed, Inc. (the “Company”) of up to 2,300,000 shares of its common stock (which includes an over-allotment option of up to 300,000 shares of Company common stock), and in accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness as of 5:00 p.m. Central Daylight Time on Monday, August 9, 2010, or as soon as practicable thereafter.
Pursuant to Rule 460 under the Act, please be advised that through the date of this letter, we have effected the following distribution of the Company’s Preliminary Prospectus, dated July 6, 2010:
Underwriters
Dealers
Institutions
Individuals
Others
Total
We have advised the underwriters and dealers of the above issue that they must comply with the provisions of SEC Release No. 33-4968 of the Act and Rule 15c2-8 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We wish to advise you that copies of the preliminary prospectus have been made available in sufficient time for distribution to all prospective purchasers no less than 48 hours prior to the time it is expected confirmations will be mailed. The undersigned has complied and will comply, and each underwriter and dealer has advised the undersigned that it has complied and will comply, with SEC Release No. 33-4968 and Rule 15c2-8 under the Exchange Act.
Sincerely,
MEMBER FINRA-SIPC
Show Raw Text
CORRESP 1 filename1.htm electromed103760_corresp.htm - Generated by SEC Publisher for SEC Filing 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, Minnesota 55402 August 5, 2010 612.492.8800 fax: 612.492.8899 wats: 866.655.3431 www.feltl.com VIA EDGAR AND EMAIL Securities and Exchange Commission Attn: Ruairi Regan Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 RE: Electromed, Inc. Registration Statement on Form S-1 (File No. 333-166470) Ladies and Gentlemen: As underwriter of the offering by Electromed, Inc. (the “Company”) of up to 2,300,000 shares of its common stock (which includes an over-allotment option of up to 300,000 shares of Company common stock), and in accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness as of 5:00 p.m. Central Daylight Time on Monday, August 9, 2010, or as soon as practicable thereafter. Pursuant to Rule 460 under the Act, please be advised that through the date of this letter, we have effected the following distribution of the Company’s Preliminary Prospectus, dated July 6, 2010: Underwriters 0 Dealers 138 Institutions 40 Individuals 743 Others 0 Total 921 We have advised the underwriters and dealers of the above issue that they must comply with the provisions of SEC Release No. 33-4968 of the Act and Rule 15c2-8 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We wish to advise you that copies of the preliminary prospectus have been made available in sufficient time for distribution to all prospective purchasers no less than 48 hours prior to the time it is expected confirmations will be mailed. The undersigned has complied and will comply, and each underwriter and dealer has advised the undersigned that it has complied and will comply, with SEC Release No. 33-4968 and Rule 15c2-8 under the Exchange Act. Sincerely, MEMBER FINRA-SIPC